Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 18, 2022
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
Ed Arce Maintained (TVTX) at Strong Buy with Increased Target to $46 on, May 17th, 2022
Ed Arce of HC Wainwright & Co., Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $45 to $46 on, May 17th, 2022.
Ed has made no other calls on TVTX in the last 4 months.
There is 1 other peer that has a rating on TVTX. Out of the 1 peers that are also analyzing TVTX, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Do Kim of "Piper Sandler" Maintained at Buy with Decreased Target to $40 on, Friday, May 6th, 2022
